Please Wait.....
Report
Global T-cell Therapy Market by Indication (Hematologic Malignancies, Solid Tumours and Other Indications), by Therapy Type (CAR T-cell Therapy, TCR-based and TIL-based), by Modality (Research and Commercialized) and Region - 2023 to 2033
Market Report I 2023-01-19 I 250 Pages I Transparency Market Research
T-cell Therapy Market - Scope of Report
TMR's report on the global T-cell therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global T-cell therapy market for the period 2017-2031, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global T-cell therapy market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the T-cell therapy market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global T-cell therapy market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global T-cell therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global T-cell therapy market.
The report delves into the competitive landscape of the global T-cell therapy market. Key players operating in the global T-cell therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global T-cell therapy market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market T-cell therapy.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants' insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
- Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
- Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
- Company Information
o OneSource Business Browser
o Hoover's
o Factiva
o Bloomberg
- Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team's expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from "Secondary & Primary Sources" is cross-checked with "TMR Knowledge Repository", which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter's Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global T-cell Therapy Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Bn) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Bn) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Indication
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Bn) Analysis By Indication , 2018-2022
5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Indication , 2023-2033
5.3.1. Hematologic Malignancies
5.3.1.1. Lymphoma
5.3.1.2. Leukemia
5.3.1.3. Myeloma
5.3.2. Solid Tumors
5.3.2.1. Melanoma
5.3.2.2. Brain & Central Nervous System
5.3.2.3. Liver Cancer
5.3.2.4. Other Solid Tumors
5.3.3. Other Indications
5.4. Y-o-Y Growth Trend Analysis By Indication , 2018-2022
5.5. Absolute $ Opportunity Analysis By Indication , 2023-2033
6. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Therapy Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Bn) Analysis By Therapy Type, 2018-2022
6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Therapy Type, 2023-2033
6.3.1. CAR T-cell Therapy
6.3.2. T Cell Receptor (TCR)-based
6.3.3. Tumor Infiltrating Lymphocytes (TIL)-based
6.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2018-2022
6.5. Absolute $ Opportunity Analysis By Therapy Type, 2023-2033
7. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Modality
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Bn) Analysis By Modality , 2018-2022
7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Modality , 2023-2033
7.3.1. Research
7.3.2. Commercialized
7.4. Y-o-Y Growth Trend Analysis By Modality , 2018-2022
7.5. Absolute $ Opportunity Analysis By Modality , 2023-2033
8. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2018-2022
8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2023-2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country
9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Indication
9.2.3. By Therapy Type
9.2.4. By Modality
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Indication
9.3.3. By Therapy Type
9.3.4. By Modality
9.4. Key Takeaways
10. Latin America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Indication
10.2.3. By Therapy Type
10.2.4. By Modality
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Indication
10.3.3. By Therapy Type
10.3.4. By Modality
10.4. Key Takeaways
11. Europe T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. Rest of Europe
11.2.2. By Indication
11.2.3. By Therapy Type
11.2.4. By Modality
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Indication
11.3.3. By Therapy Type
11.3.4. By Modality
11.4. Key Takeaways
12. Asia Pacific T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. India
12.2.1.4. South Korea
12.2.1.5. Australia
12.2.1.6. Rest of APAC
12.2.2. By Indication
12.2.3. By Therapy Type
12.2.4. By Modality
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Indication
12.3.3. By Therapy Type
12.3.4. By Modality
12.4. Key Takeaways
13. MEA T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. South Africa
13.2.1.2. Saudi Arabia
13.2.1.3. UAE
13.2.1.4. Israel
13.2.1.5. Rest of MEA
13.2.2. By Indication
13.2.3. By Therapy Type
13.2.4. By Modality
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Indication
13.3.3. By Therapy Type
13.3.4. By Modality
13.4. Key Takeaways
14. Key Countries T-cell Therapy Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Indication
14.1.2.2. By Therapy Type
14.1.2.3. By Modality
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Indication
14.2.2.2. By Therapy Type
14.2.2.3. By Modality
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Indication
14.3.2.2. By Therapy Type
14.3.2.3. By Modality
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Indication
14.4.2.2. By Therapy Type
14.4.2.3. By Modality
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Indication
14.5.2.2. By Therapy Type
14.5.2.3. By Modality
14.6. Italy
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Indication
14.6.2.2. By Therapy Type
14.6.2.3. By Modality
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Indication
14.7.2.2. By Therapy Type
14.7.2.3. By Modality
14.8. U.K.
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Indication
14.8.2.2. By Therapy Type
14.8.2.3. By Modality
14.9. Spain
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Indication
14.9.2.2. By Therapy Type
14.9.2.3. By Modality
14.10. Russia
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Indication
14.10.2.2. By Therapy Type
14.10.2.3. By Modality
14.11. China
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Indication
14.11.2.2. By Therapy Type
14.11.2.3. By Modality
14.12. Japan
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Indication
14.12.2.2. By Therapy Type
14.12.2.3. By Modality
14.13. India
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Indication
14.13.2.2. By Therapy Type
14.13.2.3. By Modality
14.14. South Korea
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Indication
14.14.2.2. By Therapy Type
14.14.2.3. By Modality
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Indication
14.15.2.2. By Therapy Type
14.15.2.3. By Modality
14.16. South Africa
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Indication
14.16.2.2. By Therapy Type
14.16.2.3. By Modality
14.17. Saudi Arabia
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Indication
14.17.2.2. By Therapy Type
14.17.2.3. By Modality
14.18. UAE
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Indication
14.18.2.2. By Therapy Type
14.18.2.3. By Modality
14.19. Israel
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By Indication
14.19.2.2. By Therapy Type
14.19.2.3. By Modality
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Indication
15.3.3. By Therapy Type
15.3.4. By Modality
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Novartis AG
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Merck KGaA
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Gilead Sciences Inc.
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. TCR2 Therapeutics Inc
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Bluebird Bio Inc
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Sorrento Therapeutics
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Fate Therapeutics
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Pfizer Inc
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Amgen
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. Celgene Corporation
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
List of Tables
Table 1: Global T-cell Therapy Market Value (US$ Bn) Forecast by Region, 2018-2033
Table 2: Global T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
Table 3: Global T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
Table 4: Global T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
Table 5: North America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 6: North America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
Table 7: North America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
Table 8: North America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
Table 9: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 10: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
Table 11: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
Table 12: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
Table 13: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 14: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
Table 15: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
Table 16: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
Table 17: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 18: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
Table 19: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
Table 20: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
Table 21: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 22: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
Table 23: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
Table 24: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
List of Figures
Figure 1: Global T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
Figure 2: Global T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
Figure 3: Global T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
Figure 4: Global T-cell Therapy Market Value (US$ Bn) by Region, 2023-2033
Figure 5: Global T-cell Therapy Market Value (US$ Bn) Analysis by Region, 2018-2033
Figure 6: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 7: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 8: Global T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
Figure 9: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
Figure 10: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
Figure 11: Global T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
Figure 12: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
Figure 13: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
Figure 14: Global T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
Figure 15: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
Figure 16: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
Figure 17: Global T-cell Therapy Market Attractiveness by Indication , 2023-2033
Figure 18: Global T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
Figure 19: Global T-cell Therapy Market Attractiveness by Modality , 2023-2033
Figure 20: Global T-cell Therapy Market Attractiveness by Region, 2023-2033
Figure 21: North America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
Figure 22: North America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
Figure 23: North America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
Figure 24: North America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
Figure 25: North America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 26: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 27: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 28: North America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
Figure 29: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
Figure 30: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
Figure 31: North America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
Figure 32: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
Figure 33: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
Figure 34: North America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
Figure 35: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
Figure 36: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
Figure 37: North America T-cell Therapy Market Attractiveness by Indication , 2023-2033
Figure 38: North America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
Figure 39: North America T-cell Therapy Market Attractiveness by Modality , 2023-2033
Figure 40: North America T-cell Therapy Market Attractiveness by Country, 2023-2033
Figure 41: Latin America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
Figure 42: Latin America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
Figure 43: Latin America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
Figure 44: Latin America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
Figure 45: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 46: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 47: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 48: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
Figure 49: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
Figure 50: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
Figure 51: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
Figure 52: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
Figure 53: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
Figure 54: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
Figure 55: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
Figure 56: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
Figure 57: Latin America T-cell Therapy Market Attractiveness by Indication , 2023-2033
Figure 58: Latin America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
Figure 59: Latin America T-cell Therapy Market Attractiveness by Modality , 2023-2033
Figure 60: Latin America T-cell Therapy Market Attractiveness by Country, 2023-2033
Figure 61: Europe T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
Figure 62: Europe T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
Figure 63: Europe T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
Figure 64: Europe T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
Figure 65: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 66: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 67: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 68: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
Figure 69: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
Figure 70: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
Figure 71: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
Figure 72: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
Figure 73: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
Figure 74: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
Figure 75: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
Figure 76: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
Figure 77: Europe T-cell Therapy Market Attractiveness by Indication , 2023-2033
Figure 78: Europe T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
Figure 79: Europe T-cell Therapy Market Attractiveness by Modality , 2023-2033
Figure 80: Europe T-cell Therapy Market Attractiveness by Country, 2023-2033
Figure 81: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
Figure 82: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
Figure 83: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
Figure 84: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
Figure 85: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 86: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 87: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 88: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
Figure 89: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
Figure 90: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
Figure 91: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
Figure 92: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
Figure 93: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
Figure 94: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
Figure 95: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
Figure 96: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
Figure 97: Asia Pacific T-cell Therapy Market Attractiveness by Indication , 2023-2033
Figure 98: Asia Pacific T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
Figure 99: Asia Pacific T-cell Therapy Market Attractiveness by Modality , 2023-2033
Figure 100: Asia Pacific T-cell Therapy Market Attractiveness by Country, 2023-2033
Figure 101: MEA T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
Figure 102: MEA T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
Figure 103: MEA T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
Figure 104: MEA T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
Figure 105: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 106: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 107: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 108: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
Figure 109: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
Figure 110: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
Figure 111: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
Figure 112: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
Figure 113: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
Figure 114: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
Figure 115: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
Figure 116: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
Figure 117: MEA T-cell Therapy Market Attractiveness by Indication , 2023-2033
Figure 118: MEA T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
Figure 119: MEA T-cell Therapy Market Attractiveness by Modality , 2023-2033
Figure 120: MEA T-cell Therapy Market Attractiveness by Country, 2023-2033
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security